Hongwei Yao
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Pneumonia | 10 | 2007 | 85 |
Why?
| Smoking | 17 | 2008 | 153 |
Why?
| Pulmonary Disease, Chronic Obstructive | 9 | 2007 | 25 |
Why?
| Smoke | 9 | 2008 | 20 |
Why?
| Oxidative Stress | 9 | 2007 | 119 |
Why?
| Pulmonary Emphysema | 4 | 2008 | 24 |
Why?
| Lipopolysaccharides | 4 | 2006 | 98 |
Why?
| Tobacco | 6 | 2008 | 24 |
Why?
| NADPH Oxidase | 2 | 2007 | 21 |
Why?
| NF-kappa B | 9 | 2004 | 114 |
Why?
| Lung | 14 | 2006 | 232 |
Why?
| Sirtuin 1 | 7 | 2009 | 7 |
Why?
| Inflammation | 8 | 2008 | 208 |
Why?
| Epigenesis, Genetic | 5 | 2008 | 11 |
Why?
| Inflammation Mediators | 3 | 2009 | 56 |
Why?
| Protein Carbonylation | 2 | 2010 | 4 |
Why?
| Histone Deacetylases | 6 | 2008 | 30 |
Why?
| Superoxide Dismutase | 3 | 2010 | 46 |
Why?
| Histones | 3 | 2008 | 42 |
Why?
| Mice, Knockout | 11 | 2008 | 265 |
Why?
| Macrophages, Alveolar | 3 | 2008 | 44 |
Why?
| Mice | 19 | 2006 | 623 |
Why?
| Lung Neoplasms | 2 | 2009 | 159 |
Why?
| Signal Transduction | 7 | 2007 | 313 |
Why?
| Extracellular Matrix | 1 | 2010 | 79 |
Why?
| Animals | 25 | 2004 | 1031 |
Why?
| Bronchoalveolar Lavage Fluid | 8 | 2006 | 68 |
Why?
| Mice, Inbred C57BL | 10 | 2008 | 318 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 14 |
Why?
| Protein Kinase C | 1 | 2009 | 93 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 31 |
Why?
| I-kappa B Kinase | 5 | 2008 | 26 |
Why?
| Pravastatin | 1 | 2006 | 6 |
Why?
| Anticholesteremic Agents | 1 | 2006 | 7 |
Why?
| Cytoprotection | 1 | 2006 | 32 |
Why?
| Respiratory Distress Syndrome, Adult | 1 | 2006 | 42 |
Why?
| Protein Processing, Post-Translational | 4 | 2008 | 78 |
Why?
| Liver Cirrhosis, Experimental | 1 | 2004 | 3 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 154 |
Why?
| Isoxazoles | 1 | 2004 | 15 |
Why?
| Adjuvants, Immunologic | 1 | 2004 | 73 |
Why?
| Histone Deacetylase 2 | 4 | 2008 | 2 |
Why?
| Poly(ADP-ribose) Polymerases | 3 | 2010 | 21 |
Why?
| Oxidation-Reduction | 7 | 2007 | 124 |
Why?
| Chromatin Assembly and Disassembly | 2 | 2009 | 6 |
Why?
| Liver | 1 | 2004 | 248 |
Why?
| Aldehydes | 2 | 2008 | 19 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2008 | 18 |
Why?
| Antioxidants | 2 | 2010 | 84 |
Why?
| Lipid Peroxidation | 2 | 2008 | 23 |
Why?
| Acetylation | 4 | 2009 | 46 |
Why?
| Oxidants | 2 | 2007 | 47 |
Why?
| Chromatin | 2 | 2008 | 29 |
Why?
| Peroxidase | 2 | 2006 | 27 |
Why?
| Transcription Factor RelA | 4 | 2008 | 36 |
Why?
| Reactive Oxygen Species | 2 | 2008 | 112 |
Why?
| Phosphorylation | 5 | 2008 | 224 |
Why?
| Repressor Proteins | 2 | 2008 | 96 |
Why?
| Humans | 20 | 2007 | 1856 |
Why?
| NAD | 3 | 2010 | 41 |
Why?
| Immunoblotting | 3 | 2010 | 119 |
Why?
| Endothelium, Vascular | 2 | 2008 | 139 |
Why?
| Forkhead Transcription Factors | 2 | 2011 | 44 |
Why?
| Glutaredoxins | 2 | 2010 | 8 |
Why?
| Neutrophils | 3 | 2008 | 114 |
Why?
| Autophagy | 2 | 2010 | 7 |
Why?
| Cytokines | 2 | 2007 | 207 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2008 | 31 |
Why?
| Epigenomics | 1 | 2011 | 2 |
Why?
| Archaeal Proteins | 1 | 2011 | 5 |
Why?
| Nucleic Acids | 1 | 2011 | 10 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2008 | 94 |
Why?
| Mice, Transgenic | 2 | 2010 | 209 |
Why?
| Peroxiredoxin VI | 1 | 2010 | 2 |
Why?
| Heparitin Sulfate | 1 | 2010 | 6 |
Why?
| Metalloporphyrins | 1 | 2010 | 8 |
Why?
| Lung Compliance | 1 | 2010 | 26 |
Why?
| Elastin | 1 | 2010 | 22 |
Why?
| Pancreatic Elastase | 1 | 2010 | 8 |
Why?
| NF-E2-Related Factor 2 | 1 | 2010 | 15 |
Why?
| Myocardial Reperfusion Injury | 1 | 2011 | 29 |
Why?
| Male | 9 | 2004 | 1553 |
Why?
| Reactive Nitrogen Species | 1 | 2010 | 9 |
Why?
| Sirtuins | 1 | 2010 | 7 |
Why?
| Rheology | 1 | 2010 | 28 |
Why?
| Drug Resistance | 1 | 2010 | 83 |
Why?
| Isonicotinic Acids | 1 | 2010 | 2 |
Why?
| Swine | 1 | 2010 | 95 |
Why?
| Free Radical Scavengers | 1 | 2010 | 26 |
Why?
| Indazoles | 1 | 2010 | 5 |
Why?
| Cell Line | 6 | 2008 | 375 |
Why?
| Sulfhydryl Compounds | 1 | 2010 | 42 |
Why?
| Phenols | 1 | 2010 | 20 |
Why?
| Stilbenes | 1 | 2010 | 16 |
Why?
| Cell Count | 2 | 2006 | 163 |
Why?
| NF-kappa B p50 Subunit | 1 | 2009 | 23 |
Why?
| Heart | 1 | 2011 | 88 |
Why?
| Glutathione | 2 | 2008 | 65 |
Why?
| Tobacco Smoke Pollution | 1 | 2010 | 35 |
Why?
| Flavonoids | 1 | 2010 | 46 |
Why?
| Stress, Mechanical | 1 | 2010 | 93 |
Why?
| Active Transport, Cell Nucleus | 1 | 2009 | 55 |
Why?
| Glucocorticoids | 1 | 2010 | 107 |
Why?
| Ubiquitination | 1 | 2008 | 10 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 131 |
Why?
| Mice, Inbred AKR | 1 | 2008 | 7 |
Why?
| Deoxyguanosine | 1 | 2008 | 7 |
Why?
| Malondialdehyde | 1 | 2008 | 8 |
Why?
| Toll-Like Receptor 4 | 1 | 2008 | 14 |
Why?
| Macrophages, Peritoneal | 1 | 2008 | 12 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 104 |
Why?
| Transcription Factor RelB | 1 | 2008 | 15 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2008 | 17 |
Why?
| Crosses, Genetic | 1 | 2008 | 47 |
Why?
| Bronchoalveolar Lavage | 1 | 2008 | 24 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 51 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2008 | 42 |
Why?
| Aerosols | 1 | 2008 | 39 |
Why?
| Cells, Cultured | 3 | 2008 | 447 |
Why?
| Species Specificity | 1 | 2008 | 186 |
Why?
| Endothelial Cells | 1 | 2010 | 80 |
Why?
| Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
| Chemokines | 1 | 2008 | 48 |
Why?
| Respiratory Function Tests | 1 | 2006 | 72 |
Why?
| Drug Evaluation, Preclinical | 1 | 2006 | 65 |
Why?
| Cell Cycle | 1 | 2008 | 121 |
Why?
| Albumins | 1 | 2006 | 33 |
Why?
| Organ Size | 1 | 2006 | 118 |
Why?
| Cell Nucleus | 1 | 2009 | 169 |
Why?
| Time Factors | 2 | 2008 | 896 |
Why?
| Rats, Sprague-Dawley | 2 | 2004 | 257 |
Why?
| Gene Expression Regulation | 2 | 2008 | 277 |
Why?
| Collagen Type III | 1 | 2004 | 7 |
Why?
| Carbon Tetrachloride Poisoning | 1 | 2004 | 3 |
Why?
| Hydroxyproline | 1 | 2004 | 16 |
Why?
| Alanine Transaminase | 1 | 2004 | 20 |
Why?
| Mice, Inbred BALB C | 1 | 2006 | 176 |
Why?
| Aspartate Aminotransferases | 1 | 2004 | 33 |
Why?
| Transforming Growth Factor beta1 | 1 | 2004 | 43 |
Why?
| B-Lymphocytes | 1 | 2008 | 134 |
Why?
| Nitric Oxide | 1 | 2004 | 85 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 210 |
Why?
| Transforming Growth Factor beta | 1 | 2004 | 99 |
Why?
| Rats | 2 | 2004 | 530 |
Why?
| Cell Aging | 2 | 2010 | 31 |
Why?
| Models, Biological | 3 | 2008 | 410 |
Why?
| Down-Regulation | 2 | 2010 | 150 |
Why?
| Hydrogen Peroxide | 2 | 2010 | 75 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2008 | 61 |
Why?
| Epithelial Cells | 2 | 2008 | 135 |
Why?
| Cell Proliferation | 2 | 2008 | 227 |
Why?
| Disease Models, Animal | 2 | 2008 | 349 |
Why?
| DNA-Cytosine Methylases | 1 | 2011 | 2 |
Why?
| Histone Demethylases | 1 | 2011 | 2 |
Why?
| Mice, 129 Strain | 1 | 2011 | 4 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 9 |
Why?
| DNA (Cytosine-5-)-Methyltransferase | 1 | 2011 | 5 |
Why?
| Animals, Genetically Modified | 1 | 2011 | 29 |
Why?
| Chromatography, Liquid | 1 | 2011 | 33 |
Why?
| Histone Acetyltransferases | 1 | 2011 | 20 |
Why?
| Ischemic Preconditioning, Myocardial | 1 | 2011 | 9 |
Why?
| Lysine | 1 | 2011 | 47 |
Why?
| Budesonide | 1 | 2010 | 6 |
Why?
| Cytosol | 1 | 2011 | 79 |
Why?
| Cyclic N-Oxides | 1 | 2010 | 9 |
Why?
| Dimerization | 1 | 2011 | 92 |
Why?
| Caloric Restriction | 1 | 2010 | 6 |
Why?
| Acrolein | 1 | 2010 | 7 |
Why?
| Polyphenols | 1 | 2010 | 9 |
Why?
| Catalase | 1 | 2010 | 27 |
Why?
| Adipogenesis | 1 | 2010 | 9 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 167 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 22 |
Why?
| Sequence Homology, Amino Acid | 1 | 2011 | 156 |
Why?
| Umbilical Veins | 1 | 2010 | 46 |
Why?
| Acetylcysteine | 1 | 2010 | 42 |
Why?
| Imidazoles | 1 | 2010 | 47 |
Why?
| I-kappa B Proteins | 1 | 2009 | 33 |
Why?
| Gene Targeting | 1 | 2009 | 51 |
Why?
| Serine | 1 | 2010 | 62 |
Why?
| Chemokine CCL2 | 1 | 2010 | 57 |
Why?
| Energy Metabolism | 1 | 2010 | 80 |
Why?
| Water | 1 | 2010 | 85 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 58 |
Why?
| Immune System | 1 | 2010 | 43 |
Why?
| Casein Kinase II | 1 | 2008 | 9 |
Why?
| Blotting, Western | 1 | 2011 | 275 |
Why?
| Lymphotoxin-beta | 1 | 2008 | 7 |
Why?
| Neutrophil Infiltration | 1 | 2008 | 17 |
Why?
| Acute Disease | 1 | 2010 | 271 |
Why?
| Ubiquitin | 1 | 2008 | 41 |
Why?
| Bronchi | 1 | 2008 | 45 |
Why?
| Chronic Disease | 1 | 2010 | 267 |
Why?
| Interleukin-1beta | 1 | 2008 | 36 |
Why?
| Enzyme Activation | 1 | 2010 | 177 |
Why?
| CD40 Ligand | 1 | 2008 | 51 |
Why?
| Macrophages | 1 | 2010 | 148 |
Why?
| Culture Media | 1 | 2008 | 116 |
Why?
| Amino Acid Sequence | 1 | 2011 | 319 |
Why?
| Interleukin-8 | 1 | 2008 | 54 |
Why?
| Tumor Necrosis Factors | 1 | 2007 | 13 |
Why?
| Dietary Supplements | 1 | 2007 | 34 |
Why?
| Cell Survival | 1 | 2008 | 229 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2008 | 91 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 431 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
| Molecular Sequence Data | 1 | 2011 | 404 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2008 | 113 |
Why?
| Muscle, Skeletal | 1 | 2010 | 114 |
Why?
| Interleukin-6 | 1 | 2008 | 145 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 188 |
Why?
| Immunohistochemistry | 1 | 2008 | 355 |
Why?
| Apoptosis | 1 | 2010 | 265 |
Why?
| Neoplasms | 1 | 2010 | 239 |
Why?
| Cell Differentiation | 1 | 2008 | 262 |
Why?
| Treatment Outcome | 1 | 2007 | 661 |
Why?
| Female | 1 | 2008 | 1643 |
Why?
|
|
Yao's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
